AG˹ٷ

STOCK TITAN

Invitation to Vitrolife Group's presentation of the Q2 2025 interim report

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Vitrolife (VTRLY) has scheduled the release of its Q2 2025 interim report for Thursday, July 17, 2025, at 08:00 am CEST. The company will host a conference call and webcast at 10:00 am CEST on the same day.

The presentation will be conducted in English by CEO Bronwyn Brophy O'Connor and acting CFO Helena Wennerström. The event will include a report presentation followed by a Q&A session. Presentation materials will be accessible on the Vitrolife Group website before the call, and a recording will be available afterward.

Vitrolife (VTRLY) ha programmato la pubblicazione del suo rapporto intermedio del secondo trimestre 2025 per giovedì 17 luglio 2025 alle 08:00 CEST. La società terrà una conference call e una webcast alle 10:00 CEST dello stesso giorno.

La presentazione sarà condotta in inglese dal CEO Bronwyn Brophy O'Connor e dalla CFO ad interim Helena Wennerström. L'evento comprenderà la presentazione del rapporto seguita da una sessione di domande e risposte. I materiali della presentazione saranno disponibili sul sito web del Gruppo Vitrolife prima della chiamata, e una registrazione sarà accessibile successivamente.

Vitrolife (VTRLY) ha programado la publicación de su informe intermedio del segundo trimestre de 2025 para el jueves 17 de julio de 2025 a las 08:00 CEST. La empresa realizará una conferencia telefónica y una retransmisión en vivo a las 10:00 CEST del mismo día.

La presentación será en inglés y estará a cargo del CEO Bronwyn Brophy O'Connor y la CFO interina Helena Wennerström. El evento incluirá la presentación del informe seguida de una sesión de preguntas y respuestas. Los materiales de la presentación estarán disponibles en la página web del Grupo Vitrolife antes de la llamada, y una grabación estará accesible después.

Vitrolife (VTRLY)� 2025� 7� 17� 목요� 오전 8� CEST� 2025� 2분기 중간 보고�� 발표� 예정입니�. 같은 � 오전 10� CEST� 컨퍼런스 콜과 웹캐스트� 진행합니�.

레젠테이션읶 CEO 브론� 브로� 오코�임시 CFO 헬레� 웬너스트룀� 영어� 진행합니�. 행사에는 보고� 발표왶 이어지� 질의응답 세션� 포함됩니�. 발표 자료� 통화 전에 Vitrolife 그룹 웹사이트에서 확인� � 있으�, 이후 녹화본도 제공됩니�.

Vitrolife (VTRLY) a prévu la publication de son rapport intermédiaire du deuxième trimestre 2025 pour le jeudi 17 juillet 2025 à 08h00 CEST. La société organisera une conférence téléphonique et une webdiffusion à 10h00 CEST le même jour.

La présentation sera réalisée en anglais par la PDG Bronwyn Brophy O'Connor et la directrice financière par intérim Helena Wennerström. L'événement comprendra la présentation du rapport suivie d'une séance de questions-réponses. Les documents de présentation seront accessibles sur le site du groupe Vitrolife avant l'appel, et un enregistrement sera disponible par la suite.

Vitrolife (VTRLY) hat die Veröffentlichung seines Zwischenberichts für das 2. Quartal 2025 für Donnerstag, den 17. Juli 2025, um 08:00 Uhr MESZ geplant. Das Unternehmen wird am selben Tag um 10:00 Uhr MESZ eine Telefonkonferenz und Webcast veranstalten.

Die Präsentation wird auf Englisch von CEO Bronwyn Brophy O'Connor und der geschäftsführenden CFO Helena Wennerström durchgeführt. Die Veranstaltung umfasst die Vorstellung des Berichts, gefolgt von einer Fragerunde. Präsentationsmaterialien werden vor dem Anruf auf der Website der Vitrolife-Gruppe verfügbar sein, und eine Aufzeichnung wird im Anschluss bereitgestellt.

Positive
  • None.
Negative
  • None.

GOTHENBURG, Sweden, July 3, 2025 /PRNewswire/ -- Vitrolife AB (publ) will publish its Q2 2025 interim report on Thursday, 17 July 2025 at 08:00 am CEST. A conference call for investors, analysts and financial media will be held at 10:00 am CEST the same day.

The presentation will be held in English by Bronwyn Brophy O'Connor, CEO, and Helena Wennerström, acting CFO. The conference call will begin with a presentation of the report followed by a question-and-answer session. The presentation material will be available prior to the start of the conference call on the Vitrolife Group website

To follow the webcast, please use this link.

To participate in the conference call please register via this link. After registration, you will be provided with telephone numbers and a conference ID to access the conference. You can ask questions verbally via the telephone conference.

After the event, the presentation material and a recording of the webcast will be available at

Gothenburg, 3 July 2025

VITROLIFE AB (publ)

Contact:

Amelie Wilson, Investor relations, external corporate communications and executive support,[email protected]

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

This information was brought to you by Cision

The following files are available for download:

Invitation to Vitrolife Group’s presentation of the Q2 2025 interim report

Cision View original content:

SOURCE Vitrolife AB

FAQ

When will Vitrolife (VTRLY) release its Q2 2025 earnings report?

Vitrolife will release its Q2 2025 interim report on Thursday, July 17, 2025, at 08:00 am CEST.

What time is Vitrolife's Q2 2025 earnings conference call?

The conference call and webcast will be held on July 17, 2025, at 10:00 am CEST.

Who will present at Vitrolife's Q2 2025 earnings call?

The presentation will be conducted by CEO Bronwyn Brophy O'Connor and acting CFO Helena Wennerström in English.

How can investors access Vitrolife's Q2 2025 earnings presentation materials?

The presentation materials will be available on the Vitrolife Group website (www.vitrolifegroup.com) prior to the conference call, and a recording will be available on the website after the event.
Vitrolife

OTC:VTRLY

VTRLY Rankings

VTRLY Latest News

VTRLY Stock Data

2.44B
74.98M
Medical Devices
Healthcare
Sweden
Gothenburg